Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)
China · Delayed Price · Currency is CNY 74.59
-2.55 (-3.31%)
At close: May 29, 2026
SHE:301075 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -130.77 | -132.4 | -62.67 | 18.85 | 20.5 | 68.51 |
Depreciation & Amortization | 52.31 | 52.31 | 29.26 | 18.91 | 15.77 | 14.81 |
Other Amortization | 0.32 | 0.32 | 0.47 | 0.38 | 1.13 | 1.12 |
Loss (Gain) From Sale of Assets | 0.11 | 0.11 | -0.04 | -0.08 | - | - |
Asset Writedown & Restructuring Costs | 6.78 | 6.78 | -0.26 | -0.05 | 3.07 | 1.45 |
Loss (Gain) From Sale of Investments | -0.85 | -0.85 | -5.33 | -5.65 | -0.3 | -0.18 |
Provision & Write-off of Bad Debts | - | - | 5.64 | 0.85 | - | - |
Other Operating Activities | 7.52 | 29.78 | -5.76 | -3.09 | -3.98 | -1.47 |
Change in Accounts Receivable | 16.29 | 16.29 | -32.38 | -12.99 | -4.87 | 6.57 |
Change in Inventory | -43.51 | -43.51 | -18.95 | 2.91 | -23.31 | 4.91 |
Change in Accounts Payable | 26 | 26 | 25.17 | -7.15 | -6.75 | -47.45 |
Operating Cash Flow | -66.45 | -45.83 | -67.18 | 12.41 | 1.13 | 48.15 |
Operating Cash Flow Growth | - | - | - | 1001.79% | -97.66% | -24.34% |
Capital Expenditures | -122.09 | -101.82 | -40.92 | -23.69 | -32.73 | -5.35 |
Sale of Property, Plant & Equipment | 1.18 | 0.78 | - | 0.57 | 0.01 | - |
Cash Acquisitions | - | - | -47.99 | -35.09 | - | - |
Divestitures | 8.8 | 8.8 | 60 | 0.54 | - | - |
Investment in Securities | 21.01 | 109 | -167.02 | -13.52 | -185 | - |
Other Investing Activities | 232.11 | 155.83 | 3.58 | 2.81 | 14.87 | -109.82 |
Investing Cash Flow | 141.02 | 172.58 | -192.35 | -68.38 | -202.84 | -115.16 |
Short-Term Debt Issued | - | - | 1.9 | - | - | 50 |
Long-Term Debt Issued | - | 127.7 | 167.81 | 230.1 | 100 | - |
Total Debt Issued | 82.7 | 127.7 | 169.71 | 230.1 | 100 | 50 |
Short-Term Debt Repaid | - | - | - | - | -20 | -65 |
Long-Term Debt Repaid | - | -183.91 | -111.72 | -168.57 | - | - |
Total Debt Repaid | -197.41 | -183.91 | -111.72 | -168.57 | -20 | -65 |
Net Debt Issued (Repaid) | -114.71 | -56.21 | 57.99 | 61.53 | 80 | -15 |
Issuance of Common Stock | - | - | - | - | - | 507.8 |
Repurchase of Common Stock | - | - | -20.99 | - | - | - |
Common Dividends Paid | -8.08 | -8.79 | -17.08 | -3.25 | -50.84 | -1.15 |
Other Financing Activities | -14.78 | -86.59 | 20.72 | 2.6 | 15.87 | -48.36 |
Financing Cash Flow | -137.56 | -151.59 | 40.64 | 60.87 | 45.04 | 443.29 |
Foreign Exchange Rate Adjustments | -0 | -0 | - | - | - | - |
Net Cash Flow | -63 | -24.84 | -218.88 | 4.91 | -156.68 | 376.28 |
Free Cash Flow | -188.54 | -147.65 | -108.09 | -11.28 | -31.6 | 42.8 |
Free Cash Flow Growth | - | - | - | - | - | 233.99% |
Free Cash Flow Margin | -137.46% | -95.77% | -44.92% | -3.37% | -7.88% | 8.08% |
Free Cash Flow Per Share | -2.38 | -1.86 | -1.36 | -0.14 | -0.40 | 0.66 |
Cash Income Tax Paid | 7.1 | 8.82 | 17.8 | 38.3 | 39.32 | 67.14 |
Levered Free Cash Flow | 76.24 | 43.37 | -83.69 | -9.17 | -37.18 | 11.76 |
Unlevered Free Cash Flow | 76.37 | 43.37 | -78.75 | -7.22 | -36.33 | 12.5 |
Change in Working Capital | -1.87 | -1.87 | -28.49 | -17.7 | -35.06 | -36.09 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.